Rein Therapeutics, Inc. (RNTX) — S-1 Filings
All S-1 filings from Rein Therapeutics, Inc.. Browse 2 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (2)
- S-1 Filing — Apr 28, 2026
-
Rein Therapeutics Secures $15M Equity Line, Faces LTI-03 Clinical Hold
— Sep 3, 2025 Risk: high
Rein Therapeutics, Inc. (RNTX) is a clinical-stage biopharmaceutical company focused on orphan pulmonary and fibrosis indications. The company has two product c
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX